{"2408.12095": {"publish_time": "2024-08-22", "title": "uMedSum: A Unified Framework for Advancing Medical Abstractive Summarization", "paper_summary": "Medical abstractive summarization faces the challenge of balancing\nfaithfulness and informativeness. Current methods often sacrifice key\ninformation for faithfulness or introduce confabulations when prioritizing\ninformativeness. While recent advancements in techniques like in-context\nlearning (ICL) and fine-tuning have improved medical summarization, they often\noverlook crucial aspects such as faithfulness and informativeness without\nconsidering advanced methods like model reasoning and self-improvement.\nMoreover, the field lacks a unified benchmark, hindering systematic evaluation\ndue to varied metrics and datasets. This paper addresses these gaps by\npresenting a comprehensive benchmark of six advanced abstractive summarization\nmethods across three diverse datasets using five standardized metrics. Building\non these findings, we propose uMedSum, a modular hybrid summarization framework\nthat introduces novel approaches for sequential confabulation removal followed\nby key missing information addition, ensuring both faithfulness and\ninformativeness. Our work improves upon previous GPT-4-based state-of-the-art\n(SOTA) medical summarization methods, significantly outperforming them in both\nquantitative metrics and qualitative domain expert evaluations. Notably, we\nachieve an average relative performance improvement of 11.8% in reference-free\nmetrics over the previous SOTA. Doctors prefer uMedSum's summaries 6 times more\nthan previous SOTA in difficult cases where there are chances of confabulations\nor missing information. These results highlight uMedSum's effectiveness and\ngeneralizability across various datasets and metrics, marking a significant\nadvancement in medical summarization.", "paper_summary_zh": "<paragraph>\u91ab\u7642\u6458\u8981\u6458\u8981\u9762\u81e8\u8457\u5e73\u8861\u5fe0\u5be6\u5ea6\u548c\u8cc7\u8a0a\u6027\u7684\u6311\u6230\u3002\u76ee\u524d\u7684\u6280\u8853\u901a\u5e38\u70ba\u4e86\u5fe0\u5be6\u5ea6\u800c\u72a7\u7272\u95dc\u9375\u8cc7\u8a0a\uff0c\u6216\u5728\u512a\u5148\u8003\u616e\u8cc7\u8a0a\u6027\u6642\u5f15\u5165\u865b\u69cb\u3002\u96d6\u7136\u60c5\u5883\u5b78\u7fd2 (ICL) \u548c\u5fae\u8abf\u7b49\u6280\u8853\u7684\u6700\u65b0\u9032\u5c55\u6539\u5584\u4e86\u91ab\u7642\u6458\u8981\uff0c\u4f46\u5b83\u5011\u5e38\u5e38\u5ffd\u7565\u95dc\u9375\u65b9\u9762\uff0c\u4f8b\u5982\u5fe0\u5be6\u5ea6\u548c\u8cc7\u8a0a\u6027\uff0c\u800c\u4e0d\u8003\u616e\u6a21\u578b\u63a8\u7406\u548c\u81ea\u6211\u6539\u9032\u7b49\u5148\u9032\u65b9\u6cd5\u3002\u6b64\u5916\uff0c\u8a72\u9818\u57df\u7f3a\u4e4f\u7d71\u4e00\u7684\u57fa\u6e96\uff0c\u7531\u65bc\u6307\u6a19\u548c\u8cc7\u6599\u96c6\u4e0d\u540c\u800c\u963b\u7919\u4e86\u7cfb\u7d71\u6027\u8a55\u4f30\u3002\u672c\u6587\u900f\u904e\u4f7f\u7528\u4e94\u500b\u6a19\u6e96\u5316\u6307\u6a19\uff0c\u5728\u4e09\u500b\u4e0d\u540c\u7684\u8cc7\u6599\u96c6\u4e0a\u5c0d\u516d\u7a2e\u5148\u9032\u7684\u62bd\u8c61\u6458\u8981\u65b9\u6cd5\u9032\u884c\u5168\u9762\u57fa\u6e96\u6e2c\u8a66\uff0c\u4f86\u89e3\u6c7a\u9019\u4e9b\u5dee\u8ddd\u3002\u6839\u64da\u9019\u4e9b\u767c\u73fe\uff0c\u6211\u5011\u63d0\u51fa uMedSum\uff0c\u4e00\u500b\u6a21\u7d44\u5316\u6df7\u5408\u6458\u8981\u67b6\u69cb\uff0c\u5b83\u5f15\u5165\u4e86\u65b0\u7684\u65b9\u6cd5\uff0c\u7528\u65bc\u9023\u7e8c\u865b\u69cb\u79fb\u9664\uff0c\u7136\u5f8c\u662f\u95dc\u9375\u907a\u5931\u8cc7\u8a0a\u65b0\u589e\uff0c\u78ba\u4fdd\u5fe0\u5be6\u5ea6\u548c\u8cc7\u8a0a\u6027\u3002\u6211\u5011\u7684\u7814\u7a76\u6539\u9032\u4e86\u5148\u524d\u7684\u57fa\u65bc GPT-4 \u7684\u6700\u5148\u9032 (SOTA) \u91ab\u7642\u6458\u8981\u65b9\u6cd5\uff0c\u5728\u91cf\u5316\u6307\u6a19\u548c\u5b9a\u6027\u9818\u57df\u5c08\u5bb6\u8a55\u4f30\u4e2d\u90fd\u986f\u8457\u512a\u65bc\u5b83\u5011\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u6211\u5011\u5728\u7121\u53c3\u8003\u6307\u6a19\u4e2d\u5be6\u73fe\u4e86\u76f8\u5c0d\u65bc\u5148\u524d SOTA \u5e73\u5747 11.8% \u7684\u76f8\u5c0d\u6548\u80fd\u63d0\u5347\u3002\u5728\u53ef\u80fd\u6709\u865b\u69cb\u6216\u907a\u5931\u8cc7\u8a0a\u7684\u56f0\u96e3\u6848\u4f8b\u4e2d\uff0c\u91ab\u751f\u66f4\u559c\u6b61 uMedSum \u7684\u6458\u8981\uff0c\u6bd4\u5148\u524d\u7684 SOTA \u591a 6 \u500d\u3002\u9019\u4e9b\u7d50\u679c\u7a81\u986f\u4e86 uMedSum \u5728\u5404\u7a2e\u8cc7\u6599\u96c6\u548c\u6307\u6a19\u4e2d\u7684\u6709\u6548\u6027\u548c\u666e\u904d\u6027\uff0c\u6a19\u8a8c\u8457\u91ab\u7642\u6458\u8981\u7684\u91cd\u5927\u9032\u5c55\u3002</paragraph>", "author": "Aishik Nagar et.al.", "authors": "Aishik Nagar, Yutong Liu, Andy T. Liu, Viktor Schlegel, Vijay Prakash Dwivedi, Arun-Kumar Kaliya-Perumal, Guna Pratheep Kalanchiam, Yili Tang, Robby T. Tan", "id": "2408.12095v1", "paper_url": "http://arxiv.org/abs/2408.12095v1", "repo": "null"}}